European Society of Hypertension Scientific Newsletter: Update on hypertension management: Hypertension and dysrhythmias

Journal of Hypertension

Volumn 24, Issue 2, 2006, Pages 409-411

  Baguet, Jean Philippe ^a   Erdine, Serap ^b   Mallion, Jean Michel ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANTIHYPERTENSIVE THERAPY; ARTERY EMBOLISM; BLOOD PRESSURE REGULATION; BLOOD TESTIS BARRIER; CARDIOMYOPATHY; CIRCADIAN RHYTHM; ELECTROCARDIOGRAM; HEART ATRIUM ENLARGEMENT; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE ISCHEMIA; HEART PALPITATION; HEART VENTRICLE EXTRASYSTOLE; HUMAN; HYPERTENSION; NOTE; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PUBLICATION; RISK FACTOR; SUDDEN DEATH;

EID: 33644794213     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000199806.03058.a3     Document Type: Note

References (26)

1. The AFFIRM Investigators. Baseline characteristics of patients with atrial fibrillation: the AFFIRM study. Am Heart J 2002; 143:991-1001.
2. Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith VE, Rautaharju PM. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol 1994; 74:236-241.
3. Madu EC, Baugh DS, Gbadebo TD, Dhala A, Cardoso S. Effect of ethnicity and hypertension on atrial conduction: evaluation with high-resolution P-wave signal averaging. Clin Cardiol 2001; 24:597-602.
4. Cuspidi C, Meani S, Fusi V, Valerio C, Catini E, Sala C, et al. Prevalence and correlates of left atrial enlargement in essential hypertension: role of ventricular geometry and the metabolic syndrome: the Evaluation of Target Organ Damage in Hypertension study. J Hypertens 2005; 23:875-882.
5. Lutas EM, Devereux RB, Reis G, Alderman MH, Pickering TG, Borer JS, et al. Increased cardiac performance in mild essential hypertension: left ventricular mechanics. Hypertension 1985; 7:979-988.
6. Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 1998; 82 (Suppl):2N-9N.
7. Verdecchia P, Reboldi GP, Bentivoglio M, Borgioni C, Angeli F, Carluccio E, et al. Atrial fibrillation in hypertension: predictors and outcome. Hypertension 2003; 41:218-223.
8. Cairns JA, Connolly SJ. Nonrheumatic atrial fibrillation: risk of stroke and role of antithrombotic therapy. Circulation 1991; 84:469-481.
9. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke 1991; 22:983-988.
10. Shinbane JS, Wood MA, Jensen DN, Ellenbogen KA, Fitzpatrick AP, Sheinman MM. Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies. J Am Coll Cardiol 1997; 29:709-715.
11. Pozzoli M, Cioffi G, Traversi E, Pinna GD, Cobelli F, Tavazzi L. Predictor of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure: a prospective study in 344 patients with baseline sinus rhythm. J Am Coll Cardiol 1998; 32:197-204.
12. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998; 98:946-952.
13. Schmieder RE, Schlaich MP, Klingbeil AU, Martus P. Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double-blind studies until December 1996). Nephrol Dial Transplant 1998; 13:564-569.
14. Gottdiener JS, Reda DJ, Williams DW, Materson BJ, Cushman W, Anderson RJ. Effect of single-drug therapy on reduction of left atrial size in mild to moderate hypertension: comparison of six antihypertensive agents. Circulation 1998; 98:140-148.
15. Messerli FH, Ventura HO, Elizardi DJ, Dunn FG, Frohlich ED. Hypertension and sudden death. Increased ventricular ectopic activity in left ventricular hypertrophy. Am J Med 1984; 77:18-22.
16. Levy D, Anderson KM, Savage DD, Balkus SA, Kannel WB, Castelli WP. Risk of ventricular arrhythmias in left ventricular hypertrophy: the Framingham heart study. Am J Cardiol 1987; 60:560-565.
17. McLenaghan JM, Henderson E, Morris K, Dargie HJ. Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy. N Engl J Med 1987; 317:787-792.
18. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322:1561-1566.
19. Nunez BD, Lavie KJ, Messerli FH, Schmieder RE, Caravaglia GE, Nunez M. Comparison of diastolic left ventricular filling and cardiac dysrhythmias in hypertensive patients with and without isolated septal hypertrophy. Am J Cardiol 1994; 74:585-589.
20. Malerba M, Muiesan ML, Zulli R, Rizzoni D, Calebich S, Agabiti-Rosei E. Ventricular arrhythmias and changes in blood pressure and left ventricular mass induced by antihypertensive treatment in hypertensive patients. J Hypertens 1991; 9 (Suppl 6):S162-S163.
21. Zehender M, Meinertz T, Hohnloser S, Geibel A. Prevalence of circadian variations and spontaneous variability of cardiac disorders and ECG changes suggestive of myocardial ischaemia in systemic arterial hypertension. Circulation 1992; 85:1808-1815.
22. James MA, Jones JV. Systolic wall stress and ventricular arrhythmias: the role of acute changes in blood pressure in the isolated working rat heart. Clin Sci 1990; 79:499-504.
23. Schwartz P, Larovere MT, Vanoli E. Autonomic nervous system and sudden death. Experimental basis and clinical observations for post-myocardial risk stratification. Circulation 1992; 85 (Suppl 1):177-191.
24. Messerli FH, Nunez BD, Nunez MM, Caravaglia GE. Hypertension and sudden death. Disparate effects of calcium entry blocker and diuretic therapy on cardiac dysrhythmias. Arch Intern Med 1989; 149:1263-1267.
25. Bayès de Luna A, Coumel PH, Leclercq JE. Ambulatory sudden death: mechanisms of production of fatal arrhythmias on the basis of data from 157 cases. Am Heart J 1989; 117:154-159.
26. Bikkina M, Larson MG, Levy D. Asymptomatic ventricular arrhythmias and mortality risk in subjects with left ventricular hypertrophy. J Am Coll Cardiol 1993; 22:1111-1116.